ATR
AptarGroup Inc
NYSE: ATR · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$120.99
-3.29% today
Updated 2026-05-08
Market cap
$7.98B
P/E ratio
21.42
P/S ratio
2.06x
EPS (TTM)
$5.84
Dividend yield
1.52%
52W range
$102 – $162
Volume
0.5M
WallStSmart proprietary scores
49
out of 100
Grade: C
Sell
Investment rating
4.0
Growth
C6.0
Quality
B6.0
Profitability
B4.0
Valuation
C3/9
Piotroski F-Score
Weak
2.6
Altman Z-Score
Grey zone
—
Industry rank
—
View all highly rated stocks (75+) →194 stocks currently score above 75
Price targets
Analyst target
$163.29
+34.96%
12-Month target
$123.84
+2.36%
Intrinsic (DCF)
$136.17
Margin of safety
-2.82%
2 Strong Buy4 Buy2 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Free cash flow $53.30M — positive
+ Revenue growth 10.80% QoQ
Risks
- Piotroski 3/9 — weak financial health
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $3.32B | $3.49B | $3.58B | $3.78B | $3.87B |
| Net income | $239.29M | $284.49M | $374.54M | $392.79M | $72.67M |
| EPS | — | — | — | — | $5.84 |
| Free cash flow | $163.00M | $256.84M | $349.22M | $299.58M | $53.30M |
| Profit margin | 7.20% | 8.16% | 10.45% | 10.40% | 9.98% |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-03-19 | VINCZELLER, SHIELA | Buy | 6,592 | — |
| 2026-03-19 | VINCZELLER, SHIELA | Buy | 1,694 | — |
| 2026-03-19 | TOUYA, GAEL | Buy | 8,830 | — |
Peer comparison
Smart narrative
AptarGroup Inc trades at $120.99. representing a P/E of 21.42x trailing earnings. Our Smart Value Score of 49/100 indicates the stock is fair. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 2.55, it sits in the grey zone. TTM revenue stands at $3.87B. with profit margins at 9.98%. Our DCF model estimates intrinsic value at $136.17.
Frequently asked questions
What is AptarGroup Inc's stock price?
AptarGroup Inc (ATR) trades at $120.99.
Is AptarGroup Inc overvalued?
Smart Value Score 49/100 (Grade C, Sell). DCF value $136.17.
What is the price target of AptarGroup Inc (ATR)?
The analyst target price is $163.29, representing +35.0% upside from the current price of $120.99.
What is the intrinsic value of AptarGroup Inc (ATR)?
Based on our DCF model, intrinsic value is $136.17, a -2.8% margin of safety versus $120.99.
What is AptarGroup Inc's revenue?
TTM revenue is $3.87B.
Piotroski F-Score?
3/9 — weak financial health.
Altman Z-Score?
2.55 — grey zone.
Company info
SectorHEALTHCARE
IndustryMEDICAL INSTRUMENTS & SUPPLIES
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio2.06x
ROE14.80%
Beta0.42
50D MA$128.28
200D MA$130.14
Shares out0.06B
Float0.06B
Short ratio—
Avg volume0.5M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—